Articles

Glaukos Corp Articles

October 15, 2020BioSpaceNews

Glaukos Corporation to Release Third Quarter 2020 Financial Results after Market Close on November 5

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused... See more »
September 7, 2020MarketScreenerNews

Nationally Ranked Litigation Firm Labaton Sucharow Announces Investigation of the Merger of Avedro, Inc. and Glaukos Corporation and Strongly Encourages Investors to Contact the Firm

(marketscreener.com) Labaton Sucharow LLP, a leading investor rights law firm, announces it is invest... See more »
September 4, 2020Picante TodayNews

Glaukos Announces Participation in September Investor Conferences

SAN CLEMENTE, Calif.-(BUSINESS WIRE)-Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technolo... See more »
August 24, 2020Orange County Business JournalNews

Glaukos Eyes Rebound In Glaucoma Surgeries

Glaukos Corp., a medical device and drug developer for glaucoma, corneal and retina health treatments... See more »
August 6, 2020BioSpaceNews

Glaukos Corporation Announces Second Quarter 2020 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused... See more »
June 19, 2020Orange County Business JournalNews

Future Glaukos HQ Trades for $73.5M

160,000 SF office campus sells... See more »
June 8, 2020FIRSTWORD PHARMANews

Glaukos Corporation Announces Proposed Private Offering of $200 Million of Convertible Senior Notes

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS) (the “Company” or “Glaukos”),... See more »
May 14, 2020MarketScreenerNews

Technologies Featured in Numerous Presentations at the 2020 American Society of Cataract and Refractive Surgery Virtual Annual Meeting

(marketscreener.com) Dr. Samuelson to Present First-of-its-Kind MIGS Prospective Study Demonstrating ... See more »
April 21, 2020Business WirePress Release

Glaukos Corporation to Release First Quarter 2020 Financial Results after Market Close on May 7

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical techno... See more »
March 24, 2020Business WirePress Release

GlaukosProvidesCOVID-19PandemicUpdate

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical techno... See more »
June 4, 2019Business WirePress Release

International Study Confirms Significant, Sustained IOP and Medication Reduction Following Standalone Implantation of Glaukos' iStent inject® in Glaucoma Patients with Substantial Disease Burden

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical techno... See more »
April 30, 2019Business WirePress Release

Glaukos Announces Participation in Bank of America Merrill Lynch 2019 Health Care Conference

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical techno... See more »
December 19, 2018StreetInsiderPress Release

Glaukos Announces Participation in J.P. Morgan Healthcare Conference

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical techn... See more »
December 11, 2018StreetInsiderPress Release

Glaukos iStent inject® Implantation with Concomitant Cataract Surgery Provides Sustained Reduction in IOP and Medication Burden, According to New Study

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused... See more »
December 11, 2018Business WirePress Release

Glaukos iStent inject® Implantation with Concomitant Cataract Surgery Provides Sustained Reduction in IOP and Medication Burden, According to New Study

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical techno... See more »
October 26, 2018Business WirePress Release

Glaukos Technologies Featured in Presentations at 2018 American Academy of Ophthalmology Conference

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical techno... See more »
June 13, 2018Business WirePress Release

Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of Over 30% - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery, T... See more »
May 9, 2018StreetInsiderPress Release

Glaukos Corporation Announces First Quarter 2018 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...